Biblio Discovery — Demo Discovery Service

21 results for "David J. Lederer"

Showing 1–20 · 0.31 seconds · RSS

  1. Journal Article

    Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey

    Gregory P. Cosgrove; Pauline Bianchi; Sherry Danese et al.

    BMC Pulmonary Medicine, Vol. 18 No. 1 · 2018 · English · DOAJ Scopus

    Abstract Background The diagnosis of idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) presents significant clinical challenges. To gain insights regarding the diagnostic experience of patients with ILD and to identify potential barriers to a timely and accurate…

  2. Journal Article

    Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea

    Sanja Jelic,  David J Lederer; Tessa Adams; et al.

    Vascular Health and Risk Management, Vol. 2009 No. default · 2009 · English · DOAJ Scopus

    Sanja Jelic1,  David J Lederer1, Tessa Adams1, Margherita Padeletti1, Paolo C Colombo2, Phillip Factor1, Thierry H Le Jemtel31Division of Pulmonary, Allergy, and Critical Care Medicine, 2Division of Cardiology, Columbia University College of Physicians and Surgeons, New York, NY, USA…

  3. Journal Article Full text

    Intravenous immunoglobulin for hypogammaglobulinemia after lung transplantation: a randomized crossover trial.

    David J Lederer; Nisha Philip; Debbie Rybak et al.

    PLoS ONE, Vol. 9 No. 8 · 2014 · English · DOAJ Scopus

    We aimed to determine the effects of treatment with intravenous immunoglobulin on bacterial infections in patients with hypogammaglobulinemia (HGG) after lung transplantation.We performed a randomized, double-blind, placebo-controlled two-period crossover trial of immune globulin intravenous…

    Also available at: PLOS

  4. Journal Article

    Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells

    Alexandros Strikoudis; Anna Cieślak; Lucas Loffredo et al.

    Cell Reports, Vol. 27 No. 12 · 2019 · English · DOAJ Scopus

    Summary: The pathogenesis of idiopathic pulmonary fibrosis (IPF), an intractable interstitial lung disease, is unclear. Recessive mutations in some genes implicated in Hermansky-Pudlak syndrome (HPS) cause HPS-associated interstitial pneumonia (HPSIP), a clinical entity that is similar to IPF. We…

  5. Journal Article

    Regional distribution of high-attenuation areas on chest computed tomography in the Multi-Ethnic Study of Atherosclerosis

    Bina Choi; Steven M. Kawut; Ganesh Raghu et al.

    ERJ Open Research, Vol. 6 No. 1 · 2020 · English · DOAJ Scopus

    High-attenuation areas (HAA) are a computed tomography-based quantitative measure of subclinical interstitial lung disease (ILD). We aimed to validate HAA in lung regions that are less subject to artefacts, such as extravascular lung water or dependent atelectasis. We examined the associations of…

  6. Journal Article

    Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)

    Kevin K Brown; Toby M Maher; Michael Kreuter et al.

    BMJ Open Respiratory Research, Vol. 6 No. 1 · 2019 · English · DOAJ Scopus

    Introduction While current standard of care (SOC) for idiopathic pulmonary fibrosis (IPF) slows disease progression, prognosis remains poor. Therefore, an unmet need exists for novel, well-tolerated agents that reduce lung function decline and improve quality of life. Here we report the design of…

  7. Journal Article Full text

    Chest Fat Quantification via CT Based on Standardized Anatomy Space in Adult Lung Transplant Candidates

    Yubing Tong; Jayaram K. Udupa; Drew A. Torigian et al.

    PLOS ONE, Vol. 12 No. 1 · 2017 · English · PLOS Scopus

    Purpose: Overweight and underweight conditions are considered relative contraindications to lung transplantation due to their association with excess mortality. Yet, recent work suggests that body mass index (BMI) does not accurately reflect adipose tissue mass in adults with advanced lung…

    Also available at: DOAJ

  8. Journal Article

    Development of a Patient Journey Map for Metabolic Dysfunction–Associated Steatohepatitis: A Comprehensive Assessment of the Patient Journey in North America

    David O. Garcia; Roberto A. Calle; Abhinav Seth et al.

    Journal of Patient Experience, Vol. 13 · 2026 · English · DOAJ Scopus

    Patient experience maps are valuable tools for raising awareness of the patient journey, identifying resource gaps, enhancing access to essential services, and ultimately improving patient outcomes. Here, we describe the development of a metabolic dysfunction–associated steatohepatitis (MASH)…

  9. Journal Article Full text

    Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline

    Susan S. Jacobs; Jerry A. Krishnan; David J. Lederer et al.

    American Journal of Respiratory and Critical Care Medicine · 2020 · English · OpenAlex Scopus

    Abstract Background Evidence-based guidelines are needed for effective delivery of home oxygen therapy to appropriate patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). Methods The multidisciplinary panel created six research questions using a modified…

  10. Journal Article

    AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD

    Klaus F. Rabe; Fernando J. Martinez; Surya P. Bhatt et al.

    ERJ Open Research, Vol. 10 No. 5 · 2024 · English · DOAJ Scopus

    Background Accumulating data implicate interleukin (IL)-33, a proinflammatory cytokine released locally upon epithelial cell damage, in the pathogenesis of COPD. In a phase 2 study, itepekimab, a human monoclonal antibody against IL-33, reduced exacerbations and improved lung function in a subgroup…

  11. Journal Article Full text

    Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma

    Leonard B. Bacharier; Jorge F. Maspero; Constance H. Katelaris et al.

    New England Journal of Medicine · 2021 · English · OpenAlex Scopus

    BACKGROUND: Children with moderate-to-severe asthma continue to have disease complications despite the receipt of standard-of-care therapy. The monoclonal antibody dupilumab has been approved for the treatment of adults and adolescents with asthma as well as with other type 2 inflammatory diseases…

  12. Journal Article

    Long-Term Efficacy of Dupilumab in Moderate-to-Severe Asthma Phenotyped by Blood Eosinophils and Exhaled Nitric OxideTake-home Points

    Michael E. Wechsler, MD; Ian D. Pavord, MD; Alberto Papi, MD et al.

    CHEST Pulmonary, Vol. 3 No. 1 · 2025 · English · DOAJ Scopus

    Background: Asthma treatment aims to reduce symptom severity and exacerbation risk. Dupilumab, a human monoclonal antibody, blocks the shared receptor for IL-4/IL-13, key drivers of type 2 inflammation. In the Evaluation of Dupilumab in Patients With Persistent Asthma (QUEST) study (NCT02414854)…

  13. Journal Article

    Genome-wide association study of subclinical interstitial lung disease in MESA

    Ani Manichaikul; Xin-Qun Wang; Li Sun et al.

    Respiratory Research, Vol. 18 No. 1 · 2017 · English · DOAJ Scopus

    Abstract Background We conducted a genome-wide association study (GWAS) of subclinical interstitial lung disease (ILD), defined as high attenuation areas (HAA) on CT, in the population-based Multi-Ethnic Study of Atherosclerosis Study. Methods We measured the percentage of high attenuation areas…

  14. Journal Article Full text

    Elevated Plasma Angiopoietin-2 Levels and Primary Graft Dysfunction after Lung Transplantation

    Joshua M. Diamond; Mary K. Porteous; Edward Cantu et al.

    PLoS ONE, Vol. 7 No. 12 · 2012 · English · PLOS Scopus

    Introduction: Primary graft dysfunction (PGD) is a significant contributor to early morbidity and mortality after lung transplantation. Increased vascular permeability in the allograft has been identified as a possible mechanism leading to PGD. Angiopoietin-2 serves as a partial antagonist to the…

    Also available at: DOAJ

  15. Journal Article Full text

    Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals

    Daniel E. Leisman; Michael Oscar Harhay; David J. Lederer et al.

    Critical Care Medicine · 2020 · English · OpenAlex Scopus

    Prediction models aim to use available data to predict a health state or outcome that has not yet been observed. Prediction is primarily relevant to clinical practice, but is also used in research, and administration. While prediction modeling involves estimating the relationship between patient…

  16. Journal Article Full text

    Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline

    Ganesh Raghu; Martine Rémy‐Jardin; Christopher J. Ryerson et al.

    American Journal of Respiratory and Critical Care Medicine · 2020 · English · OpenAlex Scopus

    Abstract Background This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It represents a collaborative effort among the American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana del Tórax. Methods Systematic reviews were performed for six…

  17. Journal Article Full text

    Associations of variants In the hexokinase 1 and interleukin 18 receptor regions with oxyhemoglobin saturation during sleep

    Brian E. Cade; Han Chen; Adrienne M. Stilp et al.

    PLOS Genetics, Vol. 15 No. 4 · 2019 · English · PLOS Scopus

    Sleep disordered breathing (SDB)-related overnight hypoxemia is associated with cardiometabolic disease and other comorbidities. Understanding the genetic bases for variations in nocturnal hypoxemia may help understand mechanisms influencing oxygenation and SDB-related mortality. We conducted…